Huge V - Search Results

1

Impact of a functional restoration program on pain and health-related quality of life in patients with chronic low back pain.

Huge V, Schloderer U, Steinberger M, Wuenschmann B, Schöps P, Beyer A, Azad SC. Huge V, et al. Pain Med. 2006 Nov-Dec;7(6):501-8. doi: 10.1111/j.1526-4637.2006.00238.x. Pain Med. 2006. PMID: 17112363

2

[Patients with chronic pain syndromes. Impact of an individual outpatient therapy program on pain and health-related quality of life].

Huge V, Müller E, Beyer A, Kraft E, Azad SC. Huge V, et al. Schmerz. 2010 Sep;24(5):459-67. doi: 10.1007/s00482-010-0968-1. Schmerz. 2010. PMID: 20821234 German.

3

Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain.

Huge V, Lauchart M, Magerl W, Schelling G, Beyer A, Thieme D, Azad SC. Huge V, et al. Eur J Pain. 2010 Apr;14(4):387-94. doi: 10.1016/j.ejpain.2009.08.002. Epub 2009 Sep 3. Eur J Pain. 2010. PMID: 19733106 Clinical Trial.

4

Complex interaction of sensory and motor signs and symptoms in chronic CRPS.

Huge V, Lauchart M, Magerl W, Beyer A, Moehnle P, Kaufhold W, Schelling G, Azad SC. Huge V, et al. PLoS One. 2011 Apr 29;6(4):e18775. doi: 10.1371/journal.pone.0018775. PLoS One. 2011. PMID: 21559525 Free PMC article.

5

Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse.

Huge V, Rammes G, Beyer A, Zieglgänsberger W, Azad SC. Huge V, et al. Eur J Pain. 2009 Feb;13(2):124-9. doi: 10.1016/j.ejpain.2008.03.010. Epub 2008 Apr 24. Eur J Pain. 2009. PMID: 18439862

6

Interaction of hyperalgesia and sensory loss in complex regional pain syndrome type I (CRPS I).

Huge V, Lauchart M, Förderreuther S, Kaufhold W, Valet M, Azad SC, Beyer A, Magerl W. Huge V, et al. PLoS One. 2008 Jul 23;3(7):e2742. doi: 10.1371/journal.pone.0002742. PLoS One. 2008. PMID: 18648647 Free PMC article.

7

Lymphocyte subsets and the role of TH1/TH2 balance in stressed chronic pain patients.

Kaufmann I, Eisner C, Richter P, Huge V, Beyer A, Chouker A, Schelling G, Thiel M. Kaufmann I, et al. Among authors: huge v. Neuroimmunomodulation. 2007;14(5):272-80. doi: 10.1159/000115041. Epub 2008 Feb 1. Neuroimmunomodulation. 2007. PMID: 18239379

8

Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study.

Geber C, Klein T, Azad S, Birklein F, Gierthmühlen J, Huge V, Lauchart M, Nitzsche D, Stengel M, Valet M, Baron R, Maier C, Tölle T, Treede RD. Geber C, et al. Among authors: huge v. Pain. 2011 Mar;152(3):548-556. doi: 10.1016/j.pain.2010.11.013. Epub 2011 Jan 14. Pain. 2011. PMID: 21237569

9

The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica.

Pellkofer HL, Havla J, Hauer D, Schelling G, Azad SC, Kuempfel T, Magerl W, Huge V. Pellkofer HL, et al. Among authors: huge v. PLoS One. 2013 Aug 9;8(8):e71500. doi: 10.1371/journal.pone.0071500. eCollection 2013. PLoS One. 2013. PMID: 23951176 Free PMC article.

10

Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values.

Rolke R, Baron R, Maier C, Tölle TR, Treede -DR, Beyer A, Binder A, Birbaumer N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B. Rolke R, et al. Among authors: huge v. Pain. 2006 Aug;123(3):231-243. doi: 10.1016/j.pain.2006.01.041. Epub 2006 May 11. Pain. 2006. PMID: 16697110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page